Tian-Gen Chang (Tiangen Chang)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Papillary Thyroid

Childhood Cancer

Ejection Fraction

Top Venues

bioRxiv : the preprint server for biology

Cancer research communications

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yingying Cao, Tian-Gen Chang, Fiorella Schischlik, Wang Kun, Sanju Sinha, Sridhar Hannenhalli, Peng Jiang, Eytan Ruppin
Inferring characteristics of the tumor-immune microenvironment of HNSCC patients from single-cell transcriptomics of peripheral blood. Cancer research communications (2024)
Johanna Zerbib, Marica Rosaria Ippolito, Yonatan Eliezer, Giuseppina De Feudis, Eli Reuveni, Anouk Savir Kadmon, Sara Martin, Sonia Viganò, Gil Leor, James Berstler, Julia Muenzner, Michael Mulleder, Emma M Campagnolo, Eldad David Shulman, Tian-Gen Chang, Carmela Rubolino, Kathrin Laue, Yael Cohen-Sharir, Simone Scorzoni, Silvia Taglietti, Alice Ratti, Chani Stossel, Talia Golan, Francesco Nicassio, Eytan Ruppin, Markus Ralser, Francisca Vazquez, Uri Ben-David, Stefano Santaguida
Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage. Nature communications 15 (1) (2024)
Tian-Gen Chang, Yingying Cao, Hannah J Sfreddo, Saugato Rahman Dhruba, Se-Hoon Lee, Cristina Valero, Seong-Keun Yoo, Diego Chowell, Luc G T Morris, Eytan Ruppin
LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features. Nature cancer 5 (8) (2024)
Tian-Gen Chang, Yingying Cao, Hannah J Sfreddo, Saugato Rahman Dhruba, Se-Hoon Lee, Cristina Valero, Seong-Keun Yoo, Diego Chowell, Luc G T Morris, Eytan Ruppin
LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features. Nature cancer (2024)
Tian-Gen Chang, Yingying Cao, Hannah J Sfreddo, Saugato Rahman Dhruba, Se-Hoon Lee, Cristina Valero, Seong-Keun Yoo, Diego Chowell, Luc G T Morris, Eytan Ruppin
LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features. Nature cancer 5 (8) (2024)
Xiaojuan Fan, Tian-Gen Chang, Chuyun Chen, Markus Hafner, Zefeng Wang
Analysis of RNA translation with a deep learning architecture provides new insight into translation control. bioRxiv : the preprint server for biology (2024)
Tian-Gen Chang, Yingying Cao, Hannah J Sfreddo, Saugato Rahman Dhruba, Se-Hoon Lee, Cristina Valero, Seong-Keun Yoo, Diego Chowell, Luc G T Morris, Eytan Ruppin
LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features. Nature cancer (2024)
Marica Rosaria Ippolito, Johanna Zerbib, Yonatan Eliezer, Eli Reuveni, Sonia Viganò, Giuseppina De Feudis, Eldad David Shulman, Anouk Savir Kadmon, Rachel Slutsky, Tian-Gen Chang, Emma M Campagnolo, Silvia Taglietti, Simone Scorzoni, Sara Gianotti, Sara Martin, Julia Muenzner, Michael Mulleder, Nir Rozenblum, Carmela Rubolino, Tal Ben-Yishay, Kathrin Laue, Yael Cohen-Sharir, Ilaria Vigorito, Francesco Nicassio, Eytan Ruppin, Markus Ralser, Francisca Vazquez, Stefano Santaguida, Uri Ben-David
Increased RNA and protein degradation is required for counteracting transcriptional burden and proteotoxic stress in human aneuploid cells. Cancer discovery (2024)
Xiaojuan Fan, Tian-Gen Chang, Chuyun Chen, Markus Hafner, Zefeng Wang
Analysis of RNA translation with a deep learning architecture provides new insight into translation control. bioRxiv : the preprint server for biology (2024)
Tian-Gen Chang, Yingying Cao, Eldad David Shulman, Uri Ben-David, Alejandro A Schäffer, Eytan Ruppin
Optimizing cancer immunotherapy response prediction by tumor aneuploidy score and fraction of copy number alterations. NPJ precision oncology 7 (1) (2023)